妊娠期附件肿块三种预测模型的应用价值分析
本研究回顾性纳入65例经手术病理证实的妊娠期附件肿块患者,评估ADNEX、SR和O-RADS三种预测模型的诊断效能。62例(95.4%)为良性,3例(4.6%)为恶性;恶性肿块最大径中位数大于良性肿块(P<.05)。SR和O-RADS的AUC分别为0.91和0.94,显示出良好的诊断效能,但三种模型AUC差异无统计学意义。
要点
- 妊娠期附件肿块恶性率低,本组仅4.6%为恶性。
- 恶性肿块最大径中位数(103.0 mm)明显大于良性肿块(46.0 mm)。
- SR和O-RADS模型对妊娠期附件肿块良恶性评估具有较好诊断价值。
核心结论
- 妊娠期附件肿块恶性发生率低(4.6%)。
- 恶性肿块最大径中位数显著大于良性肿块(P<.05)。
- SR和O-RADS对妊娠期附件肿块良恶性评估具有良好的诊断效能。
- ADNEX、SR和O-RADS三种模型的AUC差异无统计学意义。
研究设计与样本
- 单中心回顾性研究,纳入65例经手术病理证实的妊娠期附件肿块患者。
- 术前分别应用ADNEX、SR和O-RADS三种预测模型对附件肿块进行评估。
- 以ROC曲线下面积(AUC)、准确率、敏感度和特异度评价各模型的诊断效能。
关键影像表现/征象
- 良性肿块最大径中位数为46.0 mm,恶性肿块最大径中位数为103.0 mm。
- 恶性妊娠期附件肿块典型表现为最大径大于良性肿块。
诊断标准与关键数值
- ADNEX模型的AUC为0.64。
- SR模型的AUC为0.91。
- O-RADS模型的AUC为0.94。
- 三种模型AUC之间的差异均无统计学意义。
临床应用与阅片要点
- 妊娠期附件肿块以良性为主,超声评估时应优先采用SR和O-RADS模型。
- 肿块最大径是鉴别妊娠期附件肿块良恶性的重要参考指标。
- 发现妊娠期附件肿块最大径明显增大时,应警惕恶性可能。
局限性
- 单中心回顾性研究设计。
- 恶性病例仅3例,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Adnexal masses during pregnancy are rare. This study aimed to evaluate the clinical application value of 3 prediction models: Assessment of Different NEoplasias in the adneXa (ADNEX), Simple Rules (SR), and Ovarian-Adnexal Reporting and Data System (O-RADS) in pregnant patients with adnexal masses and summarizes the clinical and ultrasonographic characteristics of adnexal masses during pregnancy.
METHODS: A total of 65 patients confirmed by surgery and pathology were included in this retrospective single-center study. Three predictive models were applied to assess adnexal masses prior to surgery. The area under the ROC curve (AUC), accuracy, sensitivity, and specificity were calculated to evaluate the diagnostic efficiency of different models.
RESULTS: Of these cases, 62 (95.4%) were benign and 3 (4.6%) were malignant. The median diameter of benign masses was 46.0 mm, while the median maximum diameter of malignant masses was 103.0 mm. The difference in maximum diameters between the 2 groups was statistically significant (p < .05). The performance of the predictive models varied: the area under the ROC curve (AUC) was 0.64, 0.91, and 0.94 for ADNEX, SR, and O-RADS. The differences in AUCs among these models were not statistically significant.
CONCLUSIONS: The incidence of malignant adnexal masses during pregnancy is low. Malignant masses, in contrast to benign masses, typically exhibit larger maximum diameters. SR and O-RADS showed good diagnostic efficacy and had certain clinical value in evaluating the benign and malignant of adnexal masses during pregnancy.
引用
- Niu, Shen, Ding, et al. Analysis of the Application Value of Various Prediction Models for Adnexal Mass During Pregnancy: A Single-Center Retrospective Study. J Ultrasound Med. 2026. PMID: 41601398. doi:10.1002/jum.70182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。